News
Truecaller posts 19% YoY revenue growth in Q2 FY25, driven by AI tools and subscriptions despite ad and tax challenges.
Orion targets free cash flow midpoint of $55M as tariff shifts and cost actions reshape 2025 outlook
Orion extracted $27 million from working capital in Q2, primarily from inventories. Net debt-to-EBITDA closed at 3.55, "one turn higher than the high end of our target range," impacted by ...
53m
Capital Market on MSNMarksans Pharmas arm gets USFDA nod for Omeprazole 20 mg OTC tabletsThis product is bioequivalent to the reference listed drug (RLD), Prilosec Delayed-Release Tablets, 20 mg (OTC), marketed by ...
Senegal’s Diamba Sud gold project now holds 1 million ounces, Fortuna Mining says. • Indicated resources up 53% to 724,000 ounces; inferred at 285,000 ounces. • Based on new drilling; economic ...
Investment bank BNP Paribas has significantly increased its share price target on Eutelsat following the satellite operator's results on August 5th. The target ...
1h
Capital Market on MSNAU SFB rises after RBI grants in-principle nod for transitioning to universal bankMumbai, Aug. 8 -- "With this notification, AU becomes the first Small Finance Bank in India to receive this in-principle ...
Corcept's Q2 2025 saw 60% therapy demand growth despite bottlenecks. Despite near-term operational risks, we maintain ...
For the current quarter ending in September, Synaptics expects its per-share earnings to range from 90 cents to $1.20. The company said it expects revenue in the range of $280 million to $300 million ...
CHICAGO (AP) — CHICAGO (AP) — Adtalem Global Education Inc. (ATGE) on Thursday reported fiscal fourth-quarter net income of $54.2 million. On a per-share basis, the Chicago-based company said it had ...
When are tariffs a good thing for the home retail business? One could argue that there’s a momentary upside when they create ...
The rally was enough, though, to put Opendoor into the latest batch of hot momentum stocks, nicknamed the "DORK" stocks. Even ...
NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results